Article Information
History
- April 18, 2021.
Article Versions
- Version 1 (May 15, 2020 - 05:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hamad S. Alyami1,*,
- Abdallah Y Naser2,
- Eman Zmaily Dahmash2,
- Mohammed H. Alyami1 and
- Musfer S Alyami3
- 1Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia
- 2Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan
- 3College of Medicine, King Khalid University, Abha, Saudi Arabia
- ↵*Corresponding author:
Dr. Hamad S. Alyami, Assistant Professor in Drug Delivery, Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia, hsalmukalas{at}nu.edu.sa; +966 (5)00095255.
Posted April 18, 2021.
Depression and anxiety during the COVID-19 pandemic in Saudi Arabia: a cross-sectional study
